The lowest and highest of the models that produced a value. This is the spread of the methods, not a price target.
Price target range & 52-week position
Bear₹0.56Fair value₹17.86Bull₹28.30
FairClose
52-week traded range
52W low ₹12.0052W high ₹20.05
The 52-week range is measured from the stored price history, not estimated.
Valuation summary
Trading below the consensus fair value
Cell Point (India) Ltd closed at ₹14.95, 16.3% below the consensus fair value of ₹17.86 drawn from 7 valuation models.
Financial DNA score 17/100 — Weak. P/E of 466.0x against the 20x sector multiple the P/E model uses.
Quantitative summary only — not investment advice.
All valuation models
DCF Valuation
₹0.56
-96.2%
Σ[CF×(1+g)^n/(1.10)^n] + TV/(1.10)^10
g=8%, r=10%, tg=3%, n=10yr
Graham Number
₹5.37
-64.1%
√(22.5 × EPS × BVPS)
EPS=0.03, BVPS=42.71 · outside Graham range (P/E 466, P/B 0.4) — asset-light, treat as a rough floor
P/E Fair Value
₹1.89
-87.4%
EPS × 63x (sector P/E)
EPS=0.03, Sector P/E=63x
EV/EBITDA
₹28.30
+89.3%
(EBITDA × 10x − Net Debt) ÷ Shares
EBITDA=130M
Book Value (P/B)
₹4.27
-71.4%
BVPS × (ROE−g)÷(r−g) [Justified P/B — RIM-based]
BVPS=42.71, ROE=1%, g=3%, r=10%
Reverse DCF
₹14.95
+0.0%
Solve for g: Price = Σ[EPS×(1+g)^n/(1.10)^n] + TV
Implied: 50% | Historical: 0%
Margin of Safety
₹1.95
-86.9%
Avg(DCF, Graham, P/E) × 75% (25% safety buffer)
Avg fair value=2.61, MoS=25%
Computed on September 12, 2026 from the most recent annual report on file and that day's closing price. Where a company has seen its earnings move sharply since its last annual report, this figure will lag the market.
Educational data only. Not a recommendation to buy, sell or hold any security.